Try our Advanced Search for more refined results
Ironshore Specialty Insurance Co. v. Akorn, Inc. et al
Case Number:
1:17-cv-03541
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
June 11, 2021
Insurer Needn't Help Cover $20M Award From Akorn Meds Suit
An Illinois federal judge ruled Friday that Ironshore Specialty Insurance Co. doesn't have to cover any part of a $20 million judgment against drugmaker Akorn Inc. over an adverse effect from one of its medications, finding that punitive damages stemming from the company's negligence aren't covered.
-
December 14, 2020
Insurer Wants No Part Of $20M Judgment In Akorn Meds Suit
Ironshore Specialty Insurance Co. is asking an Illinois federal court for a win as it seeks to avoid covering a $20 million judgment against Akorn Inc. over an adverse effect of one of its medications, saying punitive damages stemming from the company's willful conduct aren't covered.
-
June 26, 2017
Excess Insurer Says Akorn Suit Doesn't Need To Move To Ga.
Ironshore Specialty Insurance Co. on Friday asked an Illinois federal court to let its coverage dispute suit over a $20 million judgment against pharmaceutical company Akorn Inc. proceed, calling Akorn's recent attempts to dismiss or stay the case a meritless procedural ploy.
-
June 05, 2017
Akorn Says Excess Insurer Sued Too Soon Over $20M Verdict
Akorn Inc. on Friday told an Illinois federal court that excess insurer Ironshore Specialty Insurance Co. pulled the trigger too soon on a suit to escape coverage for a $20.5 million jury verdict against the pharmaceutical maker, saying it needs to wait until the judgment needs to be paid.
-
May 11, 2017
Excess Insurer Says Akorn Not Covered For $20M Verdict
Excess insurer Ironshore Specialty Insurance Co. on Thursday asked an Illinois federal court to rule that it doesn't have to cover any part of a $20.5 million jury verdict rendered against Akorn Inc. in a lawsuit alleging the pharmaceutical maker failed to warn of dangerous interactions between one of its products and common medications.